Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... for patients in this population, with a different immunogenicity profile than other erythropoiesis-stimulating agents," said Iain C. Macdougall, M.D., consultant nephrologist in the ...
2009 NOV 16 ... (NHD) compared to conventional in-center hemodialysis (ICHD) improves sensitivity to erythropoiesis stimulating agents (ESA). Results from a comparison of pre (months -6 to -1) to post ...
2009 NOV 23 ... the Dec. 2, 2009 print edition). The anemia-reducing medications, known as erythropoiesis-stimulating agents (i.e., erythropoietin and darbopoietin) or ESAs, stimulate red blood ...
2009 NOV 23 ... per 1 SD increase) in our study. Multiple correlations between biomarkers of ineffective erythropoiesis (serum iron, ferritin, and soluble transferrin receptor levels), inflammation and ...
2009 NOV 16 ... interval, 1.38 to 2.68; P<0.001). Although stroke is a recognized risk with erythropoiesis-stimulating agent (ESA) therapy, and has been identified in warnings in United States ...
2009 NOV 23 ... studies may clarify the role of HFE mutations, regulators of iron metabolism and erythropoiesis in chronic kidney disease." Brown and colleagues published their study in ...
2009 NOV 23 ... the differential proteome of erythroblasts at specific developmental stages during erythropoiesis. We initially distinguished 154 proteins differentially expressed between ...
2009 NOV 9 ... a wider biological role of erythropoietin (Epo) and Epo receptor (EpoR) not related to erythropoiesis, such as the detection of EpoR in other cells, i.e. polymorphonuclear leukocytes, ...
2009 NOV 9 ... Spring St., New York, NY 10013, USA. Keywords: Japan, Kobe, Life Sciences, Erythropoiesis, Proteomics, Biotechnology, RIKEN. This article was prepared by Hematology ...
2009 NOV 9 ... research from Louvain, Belgium, "Several studies have shown that darbepoetin alfa, an erythropoiesis-stimulating agent (ESA), can reduce transfusions and increase hemoglobin (Hb) levels in ...
2009 NOV 16 ... Washington, DC 20418, USA. Keywords: United States, Boston, Life Sciences, Erythropoiesis, Hematology, Cell Differentiation, Mass Spectrometry, Hematopoietic, Biochemistry, ...
2009 NOV 9 ... transfusion independence and is a prerequisite for sustained restoration of effective erythropoiesis." "Long-term outcome data indicate that cytogenetic response to ...
2009 NOV 9 ... the mutation. All bone marrow biopsies of JAK2(V617F)-mutated CMML showed increased erythropoiesis, a marked myeloid and megakaryocytic hyperplasia with occasionally clustered ...
2009 NOV 23 ... The expression of various genes related to early hematopoiesis, megakaryocytopoiesis/erythropoiesis, cytokine receptors and oxidative stress were analyzed by real-time RT-PCR. Friend ...
2009 NOV 23 ... USA. Keywords: City:Burlington, State:VT, Country:United States, Apoptosis, Erythropoiesis, Hematology, Immunology, University of Vermont. This article was prepared ...
